Pharmacokinetic interaction studies of amprenavir (APV), efavirenz (EFV), and a second protease inhibitor in HIV-seronegative volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Amprenavir; Efavirenz; Indinavir; Nelfinavir; Peptide hydrolase inhibitors; Ritonavir; Saquinavir
- Indications HIV infections
- Focus Pharmacokinetics
- 22 Jul 2013 Biomarkers information updated
- 16 Nov 2006 New trial record.